Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.

Canadian Journal of Urology, published by CANADIAN J UROLOGY, is a prominent peer-reviewed journal dedicated to advancing the field of urology and its allied disciplines. Established in 2000, this journal has consistently aimed to provide a platform for comprehensive research, clinical studies, and innovative practices in urology and general medicine, ensuring that professionals remain at the forefront of medical advancements. With a reputation reflected in its 2023 Scopus ranking of Q3 in both Urology and Medicine (miscellaneous), the journal serves as an essential resource for researchers and practitioners seeking to enhance their knowledge and application of urological sciences. Although it is not an Open Access journal, its impactful findings contribute significantly to the medical community in Canada and beyond, promoting evidence-based practices and contributing to better patient outcomes. As the journal converges into 2024, it continues to welcome high-quality submissions that explore critical challenges and advancements in urology.

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

The Journal of Urology stands as a premier publication in the field of urology, dedicated to advancing the understanding and treatment of urological diseases. Published by Lippincott Williams & Wilkins, this esteemed journal has maintained a strong presence since its inception in 1945, converging research and clinical practice until 2024. With an impressive impact factor that underscores its relevance and influence in the field—ranking 4th out of 120 in Urology according to Scopus—this journal is a vital resource for clinicians, researchers, and students alike. As a Q1 journal in its category for 2023, it boasts a high degree of visibility and rigorous peer-review standards, making it an essential reading for those wishing to stay abreast of the latest discoveries and technological advancements in urological health. Although it does not offer open access, the journal's commitment to disseminating high-quality research ensures its continued impact on both the academic community and clinical practice.

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

WORLD JOURNAL OF UROLOGY, published by Springer, stands as a premier journal in the field of urology, holding a commendable Q1 ranking in the 2023 category quartiles. With an ISSN of 0724-4983 and an E-ISSN of 1433-8726, this journal has been a vital resource since its inception in 1983, and continues to influence research up to 2024. Its ranking of 13th out of 120 in the Scopus Medicine Urology category, placing it in the 89th percentile, reflects its significant impact within the academic community. The journal aims to publish cutting-edge research, reviews, and clinical studies that advance knowledge in urological science and practice. Although it features no open access options, its rigorous peer-review process ensures that only the highest quality studies are disseminated, catering to a wide audience of researchers, medical professionals, and students eager to stay at the forefront of urological advancements.

AKTUELLE UROLOGIE is a prominent peer-reviewed journal aimed at advancements in the field of urology, established in 1972 and continuing its commitment to high-quality research through 2024. Published by GEORG THIEME VERLAG KG in Germany, this journal serves as a platform for researchers, clinicians, and students to share innovative findings, critical reviews, and clinical studies that advance urological science and practice. While it currently holds a Q4 category ranking in Urology according to the 2023 metrics, its relevance and targeted contributions provide an invaluable resource for understanding the evolving challenges and treatment modalities within urological care. The journal is accessible via traditional subscription models, supporting a diverse audience in both academic and clinical settings. With an ISSN of 0001-7868 and E-ISSN of 1438-8820, AKTUELLE UROLOGIE continues to be an important reference point for professionals striving to stay abreast of the latest developments in the field.

Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

The Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.

BJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.